{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T01:21:51Z","timestamp":1787275311853,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2020,9]]},"abstract":"\n Background<\/jats:title>\n The successful implementation of interventions targeted to improve kidney health requires early identification of CKD which involves screening at-risk populations as well as recognizing CKD. We aim to determine CKD screening and recognition rates, factors associated with these rates, and evaluate the effect of CKD awareness on delivery of care.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n A retrospective cohort study of veterans enrolled with Veterans Integrated Service Network 17 who had hypertension (HTN) and\/or diabetes (DM) and were seen at least twice in primary care clinics within 18 months. The final cohort of 270,170 patients (52% HTN, 5% DM, and 44% both) was examined for serum creatinine\/eGFR, urine protein\/albumin, International Classification of Diseases (ICD) codes for CKD, and nephrology referral. CKD was defined as eGFR <60 ml\/min per 1.73 m\n 2<\/jats:sup>\n and\/or urine albumin-creatinine ratio (uACR) >30 mg\/g at least twice 90 days apart. Clinical covariates, HTN control, and prescription rates of renal prudent medications and nonsteroidal anti-inflammatory drugs (NSAIDs) were assessed.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Overall, 254,831 (94%) patients had either eGFR, urine protein\/albumin, or both. However, screening for protein\/albuminuria was low (56%), particularly in patients with isolated HTN (35%). Of 254,831 patients, 92,900 (36%) had laboratory evidence of CKD and, of these, 40,586 (44%) were recognized to have CKD by ICD code and\/or nephrology referral. CKD due to presence of uACR criteria alone had the lowest recognition (19%) as compared with CKD due to eGFR criteria (44%) or both (67%). Frequency of emergency room visits, hospitalization, and cardiac and endovascular procedures requiring contrast had the highest odds and races other than white had the lower odds of screening. In contrast, CKD recognition was high in races other than white and increased with worsening eGFR and increasing uACR. In screened and recognized CKD, prescription was higher for angiotensin inhibitors, statins, and diuretics, and was lower for NSAIDs.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Although overall CKD screening rate was high, screening of protein\/albuminuria in isolated HTN and overall recognition of CKD was low in at-risk veterans. Increased recognition was associated with a favorable prescription rate for renal prudent medications.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000532020","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:25:34Z","timestamp":1594319134000},"page":"904-915","source":"Crossref","is-referenced-by-count":17,"title":["Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics"],"prefix":"10.34067","volume":"1","author":[{"given":"Shweta","family":"Bansal","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Texas Health at San Antonio, San Antonio, Texas"},{"name":"South Texas Veterans Healthcare System, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mader","sequence":"additional","affiliation":[{"name":"South Texas Veterans Healthcare System, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Pugh","sequence":"additional","affiliation":[{"name":"South Texas Veterans Healthcare System, San Antonio, Texas"},{"name":"Division of General and Hospital Medicine, Department of Medicine, University of Texas Health at San Antonio, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"B1-20230821","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"key":"B3-20230821","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.kint.2016.11.023","article-title":"Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits [published correction appears in Kidney Int 91: 1257, 2017]","volume":"91","author":"Oellgaard","year":"2017","journal-title":"Kidney Int"},{"key":"B4-20230821","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.ajkd.2017.09.017","article-title":"Population health for CKD and diabetes: Lessons From the Indian health Service","volume":"71","author":"Narva","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"B6-20230821","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000500706","article-title":"Albuminuria testing by race and ethnicity among patients with hypertension with and without diabetes","volume":"50","author":"Lee","year":"2019","journal-title":"Am J Nephrol"},{"key":"B7-20230821","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12882-018-1156-2","article-title":"Validating laboratory defined chronic kidney disease in the electronic health record for patients in primary care","volume":"20","author":"Frigaard","year":"2019","journal-title":"BMC Nephrol"},{"key":"B8-20230821","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2369-15-70","article-title":"Electronic problem list documentation of chronic kidney disease and quality of care","volume":"15","author":"Samal","year":"2014","journal-title":"BMC Nephrol"},{"key":"B9-20230821","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11606-008-0607-z","article-title":"Recognition and management of chronic kidney disease in an elderly ambulatory population","volume":"23","author":"Rothberg","year":"2008","journal-title":"J Gen Intern Med"},{"key":"B10-20230821","doi-asserted-by":"crossref","first-page":"e110535","DOI":"10.1371\/journal.pone.0110535","article-title":"Primary care detection of chronic kidney disease in adults with type-2 diabetes: The ADD-CKD study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease)","volume":"9","author":"Szczech","year":"2014","journal-title":"PLoS One"},{"key":"B11-20230821","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2369-10-25","article-title":"Low documentation of chronic kidney disease among high-risk patients in a managed care population: A retrospective cohort study","volume":"10","author":"Guessous","year":"2009","journal-title":"BMC Nephrol"},{"key":"B13-20230821","first-page":"73","article-title":"Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease","volume":"13","author":"Tiwari","year":"2007","journal-title":"Am J Manag Care"},{"key":"B15-20230821","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7326\/M17-3203","article-title":"Prevention, detection, evaluation, and management of high blood pressure in adults: Synopsis of the 2017 American College of cardiology\/American heart association hypertension guideline","volume":"168","author":"Carey","year":"2018","journal-title":"Ann Intern Med"},{"key":"B16-20230821","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: Results from the chronic renal insufficiency cohort (CRIC) study","volume":"55","author":"Muntner","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"B17-20230821","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.109.129841","article-title":"Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006","volume":"54","author":"Plantinga","year":"2009","journal-title":"Hypertension"},{"key":"B18-20230821","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","article-title":"The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide","volume":"13","author":"Buter","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"B19-20230821","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B20-20230821","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11606-010-1523-6","article-title":"Primary care management of chronic kidney disease","volume":"26","author":"Allen","year":"2011","journal-title":"J Gen Intern Med"},{"key":"B21-20230821","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u2018KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease\u2019","volume":"84","author":"Andrassy","year":"2013","journal-title":"Kidney Int"},{"key":"B22-20230821","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2005.05.016","article-title":"Treatment of hypertension in chronic kidney disease","volume":"25","author":"Toto","year":"2005","journal-title":"Semin Nephrol"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000532020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:57:04Z","timestamp":1786478224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000532020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000532020","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}